anxiety. anxiety disorder
Conditions
Interventions
Intervention 1: placebo capsules are used 1 per day for 6 weeks. Intervention 2: Intervention withomega 3capsules for each patient 1000 mg/day in 6weeks.
Treatment - Drugs
Sponsors
Vice chancellor foe research, Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: willingness to participate; primi gravidia woman from 18 years old; not having disease such as heart disease, hyperthyroidism, hypothyroidism, renal infection, diabetes mellitus; not taking any medication that effect depression such as anti depressent, SRII, no familial disorder; no psychotic problem and no psychotic consultation. Exclusion criteria: unwillingness to cooperate after the beginning of the study and showing allergic reaction to omega3.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: At the start of intervention- After intervention. Method of measurement: SF36 questionnaire.;Anxiety. Timepoint: At the start of intervention- After intervention. Method of measurement: Spileberger questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzima Sara
Fatemeh (PBUH) College of Nursing and Midwifery Shiraz University of Medical Sciences
Outcome results
None listed